James Raftery: Abaritarone for metastatic castration resistant prostate cancer—whose victory?

The decision by the National Institute for Health and Clinical Excellence (NICE) in May, after a provisional refusal in February, to recommend abaritarone acetate for metastatic castration resistant prostate cancer in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen has been hailed by most of the news media as a […]

Read More…

Jane Carthey: Responding to patient safety incidents – lessons from a South African hotel chain

Could the CEO of a South African hotel chain help the NHS improve how we respond when things go wrong? At last week’s Risky Business 2012 conference, Arthur Gillis, CEO of the largest chain of hotels in South Africa, gave a presentation about embedding an excellent customer service approach among employees working in his hotels. […]

Read More…

Richard Lehman’s journal review – 28 May 2012

JAMA  23 May 2012  Vol 307 2161    Daytime sleepiness is one of the main reasons for treating obstructive sleep apnoea, another one being the risk of cardiovascular events and hypertension in untreated OSA. Continuous positive airway pressure is the standard treatment, and observational evidence suggests that as well as keeping people more alert by day, […]

Read More…

Domhnall MacAuley: Unexpected afterthoughts on the BMJ Group Improving Health Awards

Humbled, unsettled, introspective. Mixed and strange emotions. Not the response you might have expected on such a wonderful evening. But, lets enjoy the evening first before the amateur psychology….. The BMJ Improving Health Awards—a celebration of achievement. Lashings of goodwill and enthusiasm. Tension, excitement, and showbiz. Great people, a great event, and a little sprinkling […]

Read More…

Stephen Ginn: “Moral obligation” or “a disaster for humanity and the planet?”

Is medical control of human aging a worthy goal? Despite the moisturisers you can buy it is impossible to reverse the damage of aging and very few of us will live to anywhere near the theoretical maximum of human age, estimated to be 125. Yet some people think the first person who will live substantially […]

Read More…

Gabriel Scally on Andrew Lansley’s Geneva fantasy at the World Health Assembly

Sometimes, while attending a World Health Assembly (WHA) in Geneva, I get the feeling that I am in a parallel universe where diplomat speak serves to smooth over unresolvable conflict and where we are discussing not the world as it is but a fantasyland. That feeling was never stronger than when listening to contributions from […]

Read More…

Deborah Cohen reports from the Parliamentary Select Committee on the regulation of implants

Parliamentary Select Committees are only as good as the evidence they receive. Evidence is taken in the form of written submissions, then MPs of various political persuasions gather— along with their civil servant advisers —to hear a handpicked group of people give oral presentations. But, as frequently reported in the BMJ, evidence on devices is […]

Read More…